HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Niels Birbaumer Selected Research

Neurofeedback

7/2022Psychophysiological treatment of chronic tinnitus: A review.
1/2020Real-time monitoring and regulating auditory cortex alpha activity in patients with chronic tinnitus.
1/2019Real-time fMRI neurofeedback training to improve eating behavior by self-regulation of the dorsolateral prefrontal cortex: A randomized controlled trial in overweight and obese subjects.
1/2017Volitional regulation of brain responses to food stimuli in overweight and obese subjects: A real-time fMRI feedback study.
1/2016Improving Motor Corticothalamic Communication After Stroke Using Real-Time fMRI Connectivity-Based Neurofeedback.
1/2015Neurofeedback, Self-Regulation, and Brain Imaging: Clinical Science and Fad in the Service of Mental Disorders.
1/2014Learned self-regulation of the lesioned brain with epidural electrocorticography.
1/2013Acquired self-control of insula cortex modulates emotion recognition and brain network connectivity in schizophrenia.
3/2010Real-time fMRI feedback training may improve chronic tinnitus.
3/2006Deactivation of brain areas during self-regulation of slow cortical potentials in seizure patients.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Niels Birbaumer Research Topics

Disease

32Stroke (Strokes)
11/2021 - 08/2004
13Paralysis (Palsy)
11/2021 - 03/2007
8Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
11/2021 - 02/2007
5Pain (Aches)
07/2016 - 01/2002
4Tinnitus
07/2022 - 03/2010
3Parkinson Disease (Parkinson's Disease)
06/2019 - 01/2016
3Overweight
01/2019 - 11/2007
3Obesity
01/2019 - 08/2006
3Phantom Limb (Phantom Limbs)
10/2008 - 06/2002
3Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
03/2007 - 03/2003
2Paresis (Hemiparesis)
01/2019 - 07/2013
2Locked-In Syndrome (Locked In Syndrome)
01/2019 - 11/2018
2Body Weight (Weight, Body)
01/2019 - 11/2009
2Brain Stem Infarctions (Weber Syndrome)
05/2015 - 02/2007
2Schizophrenia (Dementia Praecox)
01/2013 - 01/2013
2Neoplasms (Cancer)
02/2012 - 01/2003
2Insulin Resistance
11/2009 - 08/2006
2Periventricular Leukomalacia (Neonatal Cerebral Leukomalacia)
04/2007 - 02/2006
2Neuralgia (Stump Neuralgia)
03/2007 - 02/2004
2Hyperventilation
06/2003 - 02/2002
1Weight Loss (Weight Reduction)
01/2017
1Motor Disorders
01/2017
1Shoulder Pain
07/2016
1Mental Disorders (Mental Disorder)
01/2015
1Brain Diseases (Brain Disorder)
01/2014
1Disease Progression
09/2013
1Aphasia (Dysphasia)
06/2013
1Persistent Vegetative State (Vegetative State)
08/2012
1Alzheimer Disease (Alzheimer's Disease)
01/2012
1Pedophilia
01/2011
1Infections
10/2008
1Seizures (Absence Seizure)
08/2008
1Nervous System Diseases (Neurological Disorders)
03/2008
1Partial Epilepsies (Epilepsy, Partial)
03/2007
1Complex Regional Pain Syndromes
03/2007
1Spinal Cord Injuries (Spinal Cord Injury)
02/2007
1Social Phobia
01/2007
1Chronic Pain
01/2007
1Reflex Sympathetic Dystrophy (Reflex Sympathetic Dystrophy Syndrome)
10/2006
1Epilepsy (Aura)
03/2006
1Traumatic Amputation (Traumatic Amputations)
06/2002

Drug/Important Bio-Agent (IBA)

232- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA
11/2021 - 01/2007
5Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2019
3salicylhydroxamic acid (SHAM)IBA
01/2015 - 06/2013
3Insulin (Novolin)FDA Link
11/2009 - 08/2006
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
03/2007 - 06/2002
2Glucose (Dextrose)FDA LinkGeneric
11/2009 - 08/2006
2Biological ProductsIBA
04/2007 - 02/2006
2Memantine (Namenda)FDA Link
03/2007 - 02/2004
2N-Methylaspartate (NMDA)IBA
02/2004 - 06/2002
2Saline SolutionIBA
06/2003 - 02/2002
1Dopamine (Intropin)FDA LinkGeneric
01/2016
1Flavin-Adenine Dinucleotide (FAD)IBA
01/2015
1Insulin Detemir (Levemir)FDA Link
11/2007
13-FT (3 FT)IBA
11/2007
1Pharmaceutical PreparationsIBA
03/2007
1PlasticsIBA
10/2006
1Methylphenidate (Ritalin)FDA LinkGeneric
03/2003
1Ropivacaine (Naropin)FDA LinkGeneric
06/2002
1Drinking WaterIBA
02/2002
1Opioid Analgesics (Opioids)IBA
01/2002
1Naloxone (Narcan)FDA LinkGeneric
01/2002

Therapy/Procedure

34Brain-Computer Interfaces
11/2021 - 02/2007
12Neurofeedback
07/2022 - 03/2003
7Therapeutics
07/2022 - 04/2013
5Neurological Rehabilitation
11/2021 - 03/2008
3Orthotic Devices (Orthosis)
06/2015 - 03/2008
2Deep Brain Stimulation
06/2019 - 01/2019
2Aftercare (After-Treatment)
07/2016 - 03/2007
2Transcranial Magnetic Stimulation
03/2010 - 05/2007
2Surgical Amputation (Amputations)
10/2008 - 06/2002
2Analgesia
06/2002 - 01/2002
1Neural Prostheses
11/2018
1Artificial Limbs (Artificial Limb)
01/2015
1Transcranial Direct Current Stimulation
06/2013
1Palliative Care (Palliative Therapy)
02/2012
1Physical Therapy Modalities (Physical Therapy Technique)
09/2010
1Anesthesia
08/2004
1General Anesthesia
01/2003